IncellDX enter agreement with Accuri Cytometers

摘要

Molecular diagnostics company IncellDX has entered into a supply agreement with Accuri Cytometers to provide a complete automated solution for cervical cancer screening. The agreement will see new patented technology from In-CellDX - the HVP OncoTect - combine with Accuri C6 Flow cytometer technology.